Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia

BACKGROUND: Neonatal hyperbilirubinemia (NHb) results from increased total serum bilirubin and is a common reason for admission and readmission amongst newborn infants born in North America. The use of intravenous immunoglobulin (IVIG) therapy for treating NHb has been widely debated, and the curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasiah, Saisujani, Jegathesan, Thivia, Campbell, Douglas M., Shah, Prakeshkumar S., Sgro, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Population Study Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665189/
https://www.ncbi.nlm.nih.gov/pubmed/37491586
http://dx.doi.org/10.1038/s41390-023-02712-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665189/
https://www.ncbi.nlm.nih.gov/pubmed/37491586
http://dx.doi.org/10.1038/s41390-023-02712-0

Ejemplares similares